- ►shouxi.net AD Mooradian, MJ Haas, O Batejko, M … - Diabetes, 2005 - Am Diabetes Assoc Statins may have favorable effects on endothelial barrier function. The effect
of rosuvastatin and simvastatin therapy (10 mg/kg) for 5 weeks on blood-brain
barrier (BBB), blood-retinal barrier (BRB), and cardiac muscle permeability ... Cited by 26 - Related articles - BL Direct - All 5 versions
J Dai, GFJM Vrensen, RO Schlingemann - Brain research, 2002 - Elsevier Diabetes-related cognitive dysfunction has been recognized for many years in
humans, but the pathogenesis of this condition is poorly understood. Evidence
from animal studies suggests that altered function of the blood–brain ... Cited by 16 - Related articles - All 4 versions
BT Hawkins, TF Lundeen, KM Norwood, HL … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis Although diabetes mellitus is associated with
peripheral microvascular complications and increased risk of neurological
events, the mechanisms by which diabetes disrupts the blood–brain barrier ... Cited by 22 - Related articles - BL Direct - All 6 versions
K Tarhzaoui, A Behar, RA Lestrade, C Hort- … - Acta Physiologica Hungarica, 2008 - akademiai.com Acta Physiologica Hungarica, Volume 95 (2), pp. 195–208 (2008) DOI:
10.1556/APhysiol.95.2008.2.4 ... K Tarhzaoui 1 , A Behar 1,2 , RA Lestrade 1,2
, C Hort-Legrand 2 , ... FE Cohen-Boulakia 1,2 , PE Valensi 1 Cited by 3 - Related articles - All 2 versions
- ►aspetjournals.org HJ Maeng, MH Kim, HE Jin, SM Shin, T … - Drug Metabolism and Disposition, 2007 - ASPET The objective of this study was to investigate the transport kinetics of
cyclosporin A, a well known substrate for P-glycoprotein (P-gp), across the
blood-brain barrier (BBB), and the expression of the transporter in the ... Cited by 5 - Related articles - BL Direct - All 6 versions
S Gazarin, H Abd-El-Hady, O Gheith, M … - Journal of nephrology - ncbi.nlm.nih.gov Nephrotic dyslipidemia is a risk factor for the development of systemic
atherosclerosis, and may aggravate glomerulosclerosis and enhance progression of
glomerular disease. The greatest and most consistent reductions in LDL- ... Cited by 6 - Related articles - BL Direct
- ►physiology.org JD Huber, RL VanGilder, KA Houser - American Journal of Physiology- Heart and Circulatory …, 2006 - Am Physiological Soc This study investigated the effects of streptozotocin-induced diabetes on the
functional integrity of the blood-brain barrier in the rat at 7, 28, 56, and 90
days, using vascular space markers ranging in size from 342 to 65,000 Da. ... Cited by 17 - Related articles - BL Direct - All 4 versions
P Sicard, B Lauzier, A Oudot, D Busseuil, B … - Journal of Hypertension, 2005 - journals.lww.com Objectives: The QKD interval is measured between the onset of QRS on the ECG and
detection of last Korotkoff sound by a microphone placed on the brachial artery
while measuring BP. It is the sum of pre-ejection time and pulse ... Cited by 8 - Related articles - BL Direct - All 2 versions
- ►nih.gov BT Hawkins, SM Ocheltree, KM Norwood, RD … - Neuroscience letters, 2007 - Elsevier Investigations of the blood–brain barrier (BBB) in diabetes have yielded
contradictory results. It is possible that diabetes differentially affects
paracellular and transcellular permeabilities via modulation of tight ... Cited by 7 - Related articles - All 4 versions
MR Hovsepyan, MJ Haas, AS Boyajyan, AA … - Neuroscience letters, 2004 - Elsevier Serum S100B concentrations in type 2 diabetic subjects, but not in type 1
diabetic subjects, were significantly lower than those found in healthy
controls. There were no significant differences in serum NSE levels of ... Cited by 10 - Related articles - All 3 versions
